Galmed Pharmaceuticals
GLMD
#11038
Rank
A$7.47 M
Marketcap
A$7.00
Share price
21.05%
Change (1 day)
437.81%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2026 (TTM): -A$16.76 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$15.58 Million a decrease over its 2024 earnings that were of -A$11.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$16.76 Million7.57%
2025 -A$15.58 Million37.14%
2024 -A$11.36 Million8.75%
2023 -A$10.45 Million-61.31%
2022 -A$27 Million-44.97%
2021 -A$49.06 Million12.85%
2020 -A$43.47 Million40.61%
2019 -A$30.92 Million109.19%
2018 -A$14.78 Million-20.47%
2017 -A$18.59 Million-27%
2016 -A$25.46 Million58.6%
2015 -A$16.05 Million16.7%
2014 -A$13.76 Million-47.94%
2013 -A$26.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Evoke Pharma
EVOK
-A$7.15 Million-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-A$3.62 Billion 20,987.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-A$35.12 Million 104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-A$0.14 Billion 702.26%๐Ÿ‡บ๐Ÿ‡ธ USA